The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.

Am J Public Health

Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD.

Published: October 2015

Objectives: We explored the contribution of missed primary HIV care visits ("no-show") to observed disparities in virological failure (VF) among Black persons and persons with injection drug use (IDU) history.

Methods: We used patient-level data from 6 academic clinics, before the Centers for Disease Control and Prevention and Health Resources and Services Administration Retention in Care intervention. We employed staged multivariable logistic regression and multivariable models stratified by no-show visit frequency to evaluate the association of sociodemographic factors with VF. We used multiple imputations to assign missing viral load values.

Results: Among 10 053 patients (mean age = 46 years; 35% female; 64% Black; 15% with IDU history), 31% experienced VF. Although Black patients and patients with IDU history were significantly more likely to experience VF in initial analyses, race and IDU parameter estimates were attenuated after sequential addition of no-show frequency. In stratified models, race and IDU were not statistically significantly associated with VF at any no-show level.

Conclusions: Because missed clinic visits contributed to observed differences in viral load outcomes among Black and IDU patients, achieving an improved understanding of differential visit attendance is imperative to reducing disparities in HIV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566539PMC
http://dx.doi.org/10.2105/AJPH.2015.302695DOI Listing

Publication Analysis

Top Keywords

viral load
12
contribution missed
8
missed clinic
8
clinic visits
8
disparities hiv
8
load outcomes
8
idu history
8
race idu
8
idu
6
visits disparities
4

Similar Publications

Objectives: This study aimed to evaluate the prevalence and characteristics of drug resistance mutations (DRMs) in patients with low-level viremia (LLV) in Southwestern China, as it has become a growing challenge in AIDS clinical practice.

Methods: This cross-sectional study was performed in Yunnan Province, Southwestern China. LLV was defined as 50-999 copies/mL of plasma viral load with antiretroviral therapy (ART) for at least 6 months.

View Article and Find Full Text PDF

Objectives: BK virus (BKV) is highly seroprevalent in humans. After primary infection, it remains latent in the urinary tract and can reactivate in immunocompromised individuals, leading to interstitial nephropathy or hemorrhagic cystitis. The BKV viral load (VL) in plasma correlates with the occurrence of nephropathy and can be monitored in kidney graft recipients; the early detection of BKV viremia can enable an early reduction of immunosuppressant drug doses and the prevention of BKV-associated nephropathy.

View Article and Find Full Text PDF

Purpose: Postherpetic neuralgia (PHN) is a type of refractory neuropathic pain that causes significant suffering, disability, economic loss, and medical burden. In this study, we aim to evaluate the efficacy and safety of interferon (IFN)-α1b injection into the intervertebral foramen of patients with PHN.

Patients And Methods: This is a study protocol for a randomized, double-blind placebo-controlled multicenter clinical trial.

View Article and Find Full Text PDF

Background: Despite efforts to promote optimal breastfeeding practices, the practice of exclusive breastfeeding is low in South Africa. We conducted a trial to determine whether text messaging plus motivational interviewing prolonged exclusive breastfeeding during the first six months of life and improved child health outcomes.

Methods: We conducted a randomized parallel group-controlled trial between July 2022 and May 2024, at a secondary-level healthcare facility.

View Article and Find Full Text PDF

Piscine orthoreovirus (PRV) is a virus that is widely distributed among global aquaculture populations of salmonid species. The coho salmon (Oncorhynchus kisutch) is a species of increasing productive and economic importance in Chile. The presence of PRV has generated concern about its impact on the health and welfare of this species.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!